PUBLISHER: Acute Market Reports | PRODUCT CODE: 1234362
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1234362
Respiratory Syncytial Virus (RSV) Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
Respiratory Syncytial Virus (RSV) Diagnostics Market Expected to Grow at 9.5% by 2030. Respiratory Syncytial Virus (RSV) is a single-stranded RNA virus that causes respiratory infections such as pneumonia, bronchiolitis and among others. In tropical climates, RSV infection is more prominent during the rainy season. RSV infections cause a considerable burden on the global economy due to the high infection rate. According to the Centers for Disease Control and Prevention, an approximate of 150,000 hospitalizations (on average) are a result of RSV infections each year in the United States. The high incidence of the RSV infection, and unmet need for specific, rapid, and sensitive diagnostic techniques are the prime factors accounting for the RSV diagnostics market growth.
The global RSV diagnostics market is categorized based on the diagnostic technologies, end-users, and geography. Based on the diagnostic technology types, the global market is segmented into molecular diagnostics, immunoassays, monoclonal antibodies, flow cytometry, diagnostic imaging, chromatography, gel microdroplets, and other technologies. Among these, molecular diagnostics have higher specificity and sensitivity that accounts for the higher preference. Thus, in 2021, the molecular diagnostics segment dominated the global RSV diagnostics market.
Based on end-users, the global market is dominated by hospitals segmented owing to the high patient visits with RSV infection. However, the commercial health laboratories have gained attention in last few years and expected to be one of the fastest growing segment during the forecast period.
North America dominated the global RSV diagnostics market in 2021 owing to the rising patient pool with RSV infections and technological advancements in point-of-care molecular diagnostic devices. According to the data published by the Centers for Disease Control and Prevention (CDC), around 50,000 deaths were reported in 2012 due to pneumonia in the United States. Furthermore, Asia Pacific is identified to surge at fastest rate during the forecast period. High prevalence of bronchitis and pneumonia in this region accounted for the fastest growth during the forecast period.
Key market players hold the major market share and the rest of the market is occupied by the local players. The key players adopted certain organic and inorganic strategies to penetrate into the market. For instance, Abbott received US FDA clearance and CLIA waiver for its Alere Reader Lateral Flow Assay Analyzer and Alere i RSV Rapid Molecular Test in 2016. Furthermore, after the establishment of Abbott diagnostics division in India (2016), the company acquired Alere Medical (U.S.) in 2017. Such strategies are further adopted by other key players accounting for market growth.
RSV Diagnostics Market Dynamics
Drivers
Increasing Burden of RSV Infections
Growing Demand for Point-Of-Care Molecular Diagnostic Tests for the Diagnosis of RSV Infections
Increasing Adoption of Molecular Diagnostics Over Immunoassays
Increasing Approval of RSV Diagnostic Kits and Assays
Restraint
Low Detection Limits of Immunoassays
Opportunities
Technological Advancements in Diagnostic Methods
Threats
Development of RSV Vaccines
Key Players Identified in RSV Diagnostics Market include:
Abbott Laboratories, Inc., bioMerieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., EMD Millipore, Thermo Fisher Scientific, Inc. And Others.
Historical & Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Respiratory Syncytial Virus (RSV) Diagnostics market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report:
Micro and macro environment factors that are currently influencing the Respiratory Syncytial Virus (RSV) Diagnostics market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Diagnostic Technology
Molecular Diagnostics
Immunoassays
Monoclonal Antibodies
Flow Cytometry
Diagnostic Imaging
Chromatography
Gel Microdroplets
Other Technologies (Differential Light Scattering, Liposomes etc.)
End-users
Hospitals
Nursing Homes
Commercial Laboratories
Public Health Laboratories
Region Segment (2021-2031; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Global Impact of COVID-19 Segment (2020-2021; US$ Million )
Pre COVID-19 situation
Post COVID-19 situation
Key questions answered in this report:
What are the key micro and macro environmental factors that are impacting the growth of Respiratory Syncytial Virus (RSV) Diagnostics market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2031.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Respiratory Syncytial Virus (RSV) Diagnostics market?
Which is the largest regional market for Respiratory Syncytial Virus (RSV) Diagnostics market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Respiratory Syncytial Virus (RSV) Diagnostics market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Respiratory Syncytial Virus (RSV) Diagnostics market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Respiratory Syncytial Virus (RSV) Diagnostics Market
- 2.2. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By Diagnostic Technology, 2021 (US$ Million)
- 2.3. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By End-users, 2021 (US$ Million)
- 2.4. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By Geography, 2021 (US$ Million)
- 2.5. Attractive Investment Proposition by Geography, 2021
3. Respiratory Syncytial Virus (RSV) Diagnostics Market: Competitive Analysis
- 3.1. Market Positioning of Key Respiratory Syncytial Virus (RSV) Diagnostics Market Vendors
- 3.2. Strategies Adopted by Respiratory Syncytial Virus (RSV) Diagnostics Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2021 Versus 2030
4. Respiratory Syncytial Virus (RSV) Diagnostics Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Value, 2020 - 2030, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
5. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2021 Versus 2030
- 5.3. Market Segmentation
- 5.3.1. Molecular Diagnostics
- 5.3.2. Immunoassays
- 5.3.3. Monoclonal Antibodies
- 5.3.4. Flow Cytometry
- 5.3.5. Diagnostic Imaging
- 5.3.6. Chromatography
- 5.3.7. Gel Microdroplets
- 5.3.8. Other Technologies (Differential Light Scattering, Liposomes etc.)
6. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2021 Versus 2030
- 6.3. Market Segmentation
- 6.3.1. Hospitals
- 6.3.2. Nursing Homes
- 6.3.3. Commercial Laboratories
- 6.3.4. Public Health Laboratories
7. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, 2020-2030, USD (Million)
- 7.1. Market Overview
- 7.2. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 7.3. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 7.4.Respiratory Syncytial Virus (RSV) Diagnostics Market: By Region, 2020-2030, USD (Million)
- 7.4.1.North America
- 7.4.1.1. U.S.
- 7.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 7.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 7.4.1.2. Canada
- 7.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 7.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 7.4.1.3. Rest of North America
- 7.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 7.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 7.4.1.1. U.S.
- 7.4.1.North America
8. UK and European Union Respiratory Syncytial Virus (RSV) Diagnostics Market, 2020-2030, USD (Million)
- 8.1. Market Overview
- 8.2. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 8.3. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 8.4.Respiratory Syncytial Virus (RSV) Diagnostics Market: By Region, 2020-2030, USD (Million)
- 8.4.1.UK and European Union
- 8.4.1.1. UK
- 8.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 8.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 8.4.1.2. Germany
- 8.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 8.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 8.4.1.3. Spain
- 8.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 8.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 8.4.1.4. Italy
- 8.4.1.4.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 8.4.1.4.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 8.4.1.5. France
- 8.4.1.5.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 8.4.1.5.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 8.4.1.6. Rest of Europe
- 8.4.1.6.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 8.4.1.6.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 8.4.1.1. UK
- 8.4.1.UK and European Union
9. Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, 2020-2030, USD (Million)
- 9.1. Market Overview
- 9.2. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 9.3. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 9.4.Respiratory Syncytial Virus (RSV) Diagnostics Market: By Region, 2020-2030, USD (Million)
- 9.4.1.Asia Pacific
- 9.4.1.1. China
- 9.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 9.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 9.4.1.2. Japan
- 9.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 9.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 9.4.1.3. India
- 9.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 9.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 9.4.1.4. Australia
- 9.4.1.4.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 9.4.1.4.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 9.4.1.5. South Korea
- 9.4.1.5.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 9.4.1.5.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 9.4.1.6. Rest of Asia Pacific
- 9.4.1.6.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 9.4.1.6.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 9.4.1.1. China
- 9.4.1.Asia Pacific
10. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, 2020-2030, USD (Million)
- 10.1. Market Overview
- 10.2. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 10.3. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 10.4.Respiratory Syncytial Virus (RSV) Diagnostics Market: By Region, 2020-2030, USD (Million)
- 10.4.1.Latin America
- 10.4.1.1. Brazil
- 10.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 10.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 10.4.1.2. Mexico
- 10.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 10.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 10.4.1.3. Rest of Latin America
- 10.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 10.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 10.4.1.1. Brazil
- 10.4.1.Latin America
11. Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, 2020-2030, USD (Million)
- 11.1. Market Overview
- 11.2. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 11.3. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 11.4.Respiratory Syncytial Virus (RSV) Diagnostics Market: By Region, 2020-2030, USD (Million)
- 11.4.1.Middle East and Africa
- 11.4.1.1. GCC
- 11.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 11.4.1.1.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 11.4.1.2. Africa
- 11.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 11.4.1.2.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 11.4.1.3. Rest of Middle East and Africa
- 11.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By Diagnostic Technology, 2020-2030, USD (Million)
- 11.4.1.3.1. Respiratory Syncytial Virus (RSV) Diagnostics Market: By End-users, 2020-2030, USD (Million)
- 11.4.1.1. GCC
- 11.4.1.Middle East and Africa
12. Company Profile
- 12.1. Abbott Laboratories, Inc.
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Portfolio
- 12.1.4. Strategic Initiatives
- 12.2. bioMerieux SA
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Portfolio
- 12.2.4. Strategic Initiatives
- 12.3. Becton
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Portfolio
- 12.3.4. Strategic Initiatives
- 12.4. Dickinson and Company
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Portfolio
- 12.4.4. Strategic Initiatives
- 12.5. Bio-Rad Laboratories, Inc.
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Portfolio
- 12.5.4. Strategic Initiatives
- 12.6. EMD Millipore
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Portfolio
- 12.6.4. Strategic Initiatives
- 12.7. Thermo Fisher Scientific, Inc.
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Portfolio
- 12.7.4. Strategic Initiatives
- 12.8. Others
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Portfolio
- 12.8.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 2 Global Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 3 North America Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 4 North America Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 5 U.S. Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 6 U.S. Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 7 Canada Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 8 Canada Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 9 Rest of North America Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 10 Rest of North America Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 11 UK and European Union Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 12 UK and European Union Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 13 UK Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 14 UK Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 15 Germany Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 16 Germany Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 17 Spain Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 18 Spain Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 19 Italy Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 20 Italy Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 21 France Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 22 France Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 23 Rest of Europe Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 24 Rest of Europe Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 25 Asia Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 26 Asia Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 27 China Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 28 China Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 29 Japan Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 30 Japan Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 31 India Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 32 India Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 33 Australia Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 34 Australia Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 35 South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 36 South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 37 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 38 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 39 Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 40 Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 41 Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 42 Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 43 Rest of Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 44 Rest of Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 45 Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 46 Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 47 GCC Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 48 GCC Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 49 Africa Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 50 Africa Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
- TABLE 51 Rest of Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market By Diagnostic Technology, 2020-2030, USD (Million)
- TABLE 52 Rest of Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market By End-users, 2020-2030, USD (Million)
List of Figures
- FIG. 1 Global Respiratory Syncytial Virus (RSV) Diagnostics Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Respiratory Syncytial Virus (RSV) Diagnostics Market: Quality Assurance
- FIG. 5 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By Diagnostic Technology, 2021
- FIG. 6 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By End-users, 2021
- FIG. 7 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By Geography, 2021
- FIG. 8 Market Geographical Opportunity Matrix - Global Respiratory Syncytial Virus (RSV) Diagnostics Market, 2021
- FIG. 9 Market Positioning of Key Respiratory Syncytial Virus (RSV) Diagnostics Market Players, 2021
- FIG. 10 Global Respiratory Syncytial Virus (RSV) Diagnostics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
- FIG. 11 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By Diagnostic Technology, 2021 Vs 2030, %
- FIG. 12 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By End-users, 2021 Vs 2030, %
- FIG. 13 U.S. Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 14 Canada Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 15 Rest of North America Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 16 UK Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 17 Germany Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 18 Spain Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 19 Italy Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 20 France Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 21 Rest of Europe Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 22 China Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 23 Japan Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 24 India Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 25 Australia Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 26 South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 27 Rest of Asia Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 28 Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 29 Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 30 Rest of Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 31 GCC Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 32 Africa Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
- FIG. 33 Rest of Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market (US$ Million), 2020 - 2030
